Bharat Biotech is a Pharmaceuticals company located in Hyderabad, India. They are engaged in affordable manufacturing vaccines, bio-therapeutics and health care products with high quality to help people.
In worldwide, most of the scientists were in the research to find the vaccine for the deadly Corona virus disease that has infected over 11 million people and caused more than 534k deaths.
Recently, India’s indigenous COVID-19 vaccine is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV) with high containment facilities.
- The vaccine got a Drugs Controller General of India (DCGI) approval for Phase I & II Human Clinical Trials and the trials will commence across India from July, 2020.
- This is the first vaccine being developed by India and is one of the top priority projects which is being monitored at the topmost level of the Government.
- This vaccine is derived from a SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the pre-clinical development of this vaccine.
The ICMR planned to launch the vaccine for public health use by August 15, Independence Day after the completion of all the trials.
Also the Vaccines can be categorized into two types as Inactivated and live vaccines. This will come under the category of inactivated vaccines like Hepatitis A, influenza, and polio vaccines that are used in India.
Once the vaccine is administered, the body produces the antibodies which fight off the novel coronavirus infection.
